In a report released today, Reni Benjamin from JMP Securities maintained a Hold rating on Inhibrx Biosciences Inc (INBX – Research Report). The company’s shares closed yesterday at $14.19.
Jan. 31, 2025 /PRNewswire/ -- SAR, a data analytics company specialized in the securities litigation risk ... This independent, semi-annual U.S. equity research report presents an appendix with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback